Of note, for skeletal involvement, PSMA-TV derived from PSMA PET/CT outperformed CT for correlation with BR, thereby indicating a tight link between molecular-imaging-based TV and response to prostate-cancer-specific treatment [3]. This evidence concerns the gene FOLH1 and Familial prostate cancer.